Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) has a beta value of 0.05 and has seen 2.62 million shares traded in the recent trading session. The company, currently valued at $32.61M, closed the recent trade at $0.70 per share which meant it lost -$0.25 on the day or -26.61% during that session. The RVPH stock price is -511.43% off its 52-week high price of $4.28 and 14.29% above the 52-week low of $0.60. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.49 million shares traded. The 3-month trading volume is 1.47 million shares.
The consensus among analysts is that Reviva Pharmaceuticals Holdings Inc (RVPH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.23.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Sporting -26.61% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the RVPH stock price touched $0.70 or saw a rise of 40.17%. Year-to-date, Reviva Pharmaceuticals Holdings Inc shares have moved -61.33%, while the 5-day performance has seen it change -38.05%. Over the past 30 days, the shares of Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) have changed -45.31%. Short interest in the company has seen 2.85 million shares shorted with days to cover at 2.57.
Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts
The company’s shares have lost -48.15% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%. Earnings growth for 2025 is a modest 21.85% while over the next 5 years, the company’s earnings are expected to increase by 29.90%.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc is expected to release its next earnings report on 2025-Mar-30 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Insiders own 14.30% of the company shares, while shares held by institutions stand at 29.49% with a share float percentage of 34.41%. Investors are also buoyed by the number of investors in a company, with Reviva Pharmaceuticals Holdings Inc having a total of 47.0 institutions that hold shares in the company. The top two institutional holders are WOODLINE PARTNERS LP with over 1.59 million shares worth more than $2.04 million. As of 2024-06-30, WOODLINE PARTNERS LP held 5.2129% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.03 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.31 million and represent 4.2659% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 2.78% shares in the company for having 930.44 shares of worth $0.63 million while later fund manager owns 312.3 shares of worth $0.21 million as of Dec 31, 2024, which makes it owner of about 0.93% of company’s outstanding stock.
